• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.回顾性 SARS-CoV-2 IgG 筛查在英国 COVID-19 大流行的第一波(2020 年 3 月至 6 月)期间。
J Med Virol. 2021 Oct;93(10):6050-6053. doi: 10.1002/jmv.27162. Epub 2021 Jul 6.
2
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.苏格兰对 COVID-19 的强化监测:在疫情第一波期间对 SARS-CoV-2 进行基于人群的血清流行率监测。
Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24.
3
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
4
Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020.美国国家临床实验室 2020 年 3 月至 7 月 SARS-CoV-2 免疫球蛋白 G 血清学检测结果的分析。
Popul Health Manag. 2021 Feb;24(S1):S35-S42. doi: 10.1089/pop.2020.0256. Epub 2020 Nov 19.
5
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
6
Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak.456 名来自面临 COVID-19 疫情的 8 家养老院居民的非典型症状、SARS-CoV-2 检测结果和免疫接种率。
Age Ageing. 2021 May 5;50(3):641-648. doi: 10.1093/ageing/afab050.
7
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.评价两种 SARS-CoV-2 快速 IgM-IgG 联合抗体检测试剂盒在指尖毛细血管全血样本中的性能。
PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020.
8
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.评估四种商业化的全自动 SARS-CoV-2 抗体检测试剂盒提示需要对西门子 SARS-CoV-2 IgG 检测试剂盒进行修订。
Clin Chem Lab Med. 2021 Jan 15;59(6):1143-1154. doi: 10.1515/cclm-2020-1758. Print 2021 May 26.
9
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.无症状大学生中使用逆转录-定量聚合酶链反应或基于 CRISPR 的检测方法筛查严重急性呼吸综合征冠状病毒 2 的比较。
JAMA Netw Open. 2021 Feb 1;4(2):e2037129. doi: 10.1001/jamanetworkopen.2020.37129.
10
Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.IgM/IgG 抗体检测在识别无症状严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染个体方面的显著前景。
Arch Pathol Lab Med. 2021 Jan 1;145(1):39-45. doi: 10.5858/arpa.2020-0310-SA.

本文引用的文献

1
Testing at scale during the COVID-19 pandemic.大流行期间的大规模检测。
Nat Rev Genet. 2021 Jul;22(7):415-426. doi: 10.1038/s41576-021-00360-w. Epub 2021 May 4.
2
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).英格兰抗体阳性与抗体阴性医护人员的 SARS-CoV-2 感染率:一项大型、多中心、前瞻性队列研究(SIREN)。
Lancet. 2021 Apr 17;397(10283):1459-1469. doi: 10.1016/S0140-6736(21)00675-9. Epub 2021 Apr 9.
3
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.SARS-CoV-2 中和抗体反应动力学和免疫持久性:一项纵向研究。
Lancet Microbe. 2021 Jun;2(6):e240-e249. doi: 10.1016/S2666-5247(21)00025-2. Epub 2021 Mar 23.
4
Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.回顾性低流行时期抗 SARS-CoV-2 免疫球蛋白血清学监测:一个警示故事。
J Infect. 2021 Jul;83(1):119-145. doi: 10.1016/j.jinf.2021.03.007. Epub 2021 Mar 17.
5
Humoral Responses and Serological Assays in SARS-CoV-2 Infections.体液免疫反应和血清学检测在严重急性呼吸综合征冠状病毒 2 感染中的作用。
Front Immunol. 2020 Dec 18;11:610688. doi: 10.3389/fimmu.2020.610688. eCollection 2020.
6
SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing.缺乏功能性ORF8的新型冠状病毒2变体可能会降低血清学检测的准确性。
J Immunol Methods. 2021 Jan;488:112906. doi: 10.1016/j.jim.2020.112906. Epub 2020 Oct 31.
7
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
8
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.五种 SARS-CoV-2 免疫测定法的性能特征:头对头基准比较。
Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23.
9
Humoral Immune Response to SARS-CoV-2 in Iceland.冰岛人针对 SARS-CoV-2 的体液免疫反应。
N Engl J Med. 2020 Oct 29;383(18):1724-1734. doi: 10.1056/NEJMoa2026116. Epub 2020 Sep 1.
10
Serology testing in the COVID-19 pandemic response.新冠疫情应对中的血清学检测。
Lancet Infect Dis. 2020 Sep;20(9):e245-e249. doi: 10.1016/S1473-3099(20)30517-X. Epub 2020 Jul 17.

回顾性 SARS-CoV-2 IgG 筛查在英国 COVID-19 大流行的第一波(2020 年 3 月至 6 月)期间。

Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.

机构信息

Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK.

Department of Clinical Virology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK.

出版信息

J Med Virol. 2021 Oct;93(10):6050-6053. doi: 10.1002/jmv.27162. Epub 2021 Jul 6.

DOI:10.1002/jmv.27162
PMID:34173993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8426847/
Abstract

During the "first wave" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed transmission of COVID-19 in the community by asymptomatic individuals was a real possibility. Therefore, retrospective SARS-CoV-2 immunoglobulin G (IgG) testing of archived sera from out-patients visiting University Hospitals of Leicester NHS Trust service was performed to investigate the transmission of SARS-CoV-2 in the community. A total of 1779 sera samples were tested from samples collected between 16th March and 3rd June 2020, of which 202 (11.35%) were SARS-CoV-2 IgG positive. Positivity was lowest in March (2.54%) at the beginning of the pandemic before peaking in April (17.16%) before a decline in May and June (11.16% and 12.68%, respectively). This retrospective screening offers some insight into the early patterns of SARS-CoV-2 transmission within a sampled community population during the first wave of the COVID-19 pandemic; supporting the argument for more community screening during high incidences of pandemics.

摘要

在 2019 年冠状病毒病(COVID-19)大流行的“第一波”期间(2020 年 3 月至 6 月),英国的莱斯特市受到了特别严重的打击,导致重新实施了封锁措施。尽管最初尝试在社区内进行严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的聚合酶链反应检测,但由于当地实验室无法满足需求,检测很快就被放弃了。因此,无症状个体在社区中未被诊断的 COVID-19 传播确实有可能发生。因此,对莱斯特大学医院 NHS 信托服务的门诊患者的存档血清进行了回顾性 SARS-CoV-2 免疫球蛋白 G(IgG)检测,以调查社区中 SARS-CoV-2 的传播情况。共检测了 2020 年 3 月 16 日至 6 月 3 日期间采集的 1779 份血清样本,其中 202 份(11.35%)为 SARS-CoV-2 IgG 阳性。在大流行开始时的 3 月(2.54%),阳性率最低,然后在 4 月达到高峰(17.16%),5 月和 6 月阳性率下降(分别为 11.16%和 12.68%)。这种回顾性筛查为了解 COVID-19 大流行第一波期间抽样社区人群中 SARS-CoV-2 传播的早期模式提供了一些见解;支持在大流行高发期间进行更多社区筛查的论点。